Neuronetics logo

Neuronetics Share Price Today

(NASDAQ: STIM)

Neuronetics share price is $5.42 & ₹471.37 as on 6 Mar 2025, 2.30 'hrs' IST

$5.42

0.36

(7.11%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Neuronetics share price in Dollar and Rupees. Guide to invest in Neuronetics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Neuronetics, along with analyst recommendations, forecasts, and comprehensive financials.

Neuronetics share price movements

  • Today's Low: $5.15
    Today's High: $5.84

    Day's Volatility :11.82%

  • 52 Weeks Low: $0.52
    52 Weeks High: $5.92

    52 Weeks Volatility :91.22%

Neuronetics (STIM) Returns

PeriodNeuronetics IncSector (Health Care)Index (Russel 2000)
3 Months
355.46%
3.7%
0.0%
6 Months
592.12%
-2.8%
0.0%
1 Year
34.83%
2.5%
0.0%
3 Years
90.85%
12.9%
-11.6%

Neuronetics (STIM) Key Statistics

in dollars & INR

Previous Close
$5.06
Open
$5.47
Today's High
$5.84
Today's Low
$5.15
Market Capitalization
$322.1M
Today's Volume
$3.4M
52 Week High
$5.92
52 Week Low
$0.52
Revenue TTM
$72.7M
EBITDA
$-23.5M
Earnings Per Share (EPS)
$-1.45
Profit Margin
-50.09%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-153.94%

How to invest in Neuronetics Stock (STIM) from India?

It is very easy for Indian residents to invest directly in Neuronetics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Neuronetics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Neuronetics or STIM on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Neuronetics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Neuronetics shares which would translate to 0.160 fractional shares of Neuronetics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Neuronetics, in just a few clicks!

Returns in Neuronetics (STIM) for Indian investors in Rupees

The Neuronetics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Neuronetics investment value today

Current value as on today

₹1,39,775

Returns

₹39,775

(+39.77%)

Returns from Neuronetics Stock

₹34,826 (+34.83%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Neuronetics (STIM)

157.14%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Investment in Neuronetics Shares from India has grown by 157.14% over the past 30 days, indicating increased transactional activity.

-38%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Neuronetics Stock from India on INDmoney has decreased by -38% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Neuronetics

  • Masters Capital Management LLC

    2.36%

  • Balyasny Asset Management LLC

    2.33%

  • Vanguard Group Inc

    2.01%

  • FourWorld Capital Management LLC

    1.35%

  • UBS Group AG

    0.63%

  • BlackRock Inc

    0.60%

Analyst Recommendation on Neuronetics

Buy

    80%Buy

    20%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Neuronetics(by analysts ranked 0 to 5 stars)

Based on 10 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
8
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Neuronetics Stock (STIM)

What analysts predicted

Downside of 16.97%

Target:

$4.50

Current:

$5.42

Insights on Neuronetics Stock (Ticker Symbol: STIM)

  • Price Movement

    In the last 7 days, STIM stock has moved up by 26.6%
  • Increasing Revenue

    Revenue is up for the last 3 quarters, 16.45M → 22.49M (in $), with an average increase of 14.4% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -13.34M → -12.15M (in $), with an average increase of 9.7% per quarter

STIM Neuronetics Financials in INR & Dollars

FY19Y/Y Change
Revenue
$62.7M
↑ 18.72%
Net Income
$-34.3M
↑ 42.34%
Net Profit Margin
-54.74%
↓ 9.08%
FY20Y/Y Change
Revenue
$49.2M
↓ 21.41%
Net Income
$-32.3M
↓ 5.9%
Net Profit Margin
-65.55%
↓ 10.81%
FY21Y/Y Change
Revenue
$55.3M
↑ 12.32%
Net Income
$-35.6M
↑ 10.3%
Net Profit Margin
-64.37%
↑ 1.18%
FY22Y/Y Change
Revenue
$65.2M
↑ 17.89%
Net Income
$-39.2M
↑ 10.13%
Net Profit Margin
-60.13%
↑ 4.24%
FY23Y/Y Change
Revenue
$71.3M
↑ 9.42%
Net Income
$-30.2M
↓ 23.0%
Net Profit Margin
-42.31%
↑ 17.82%
FY24Y/Y Change
Revenue
$74.9M
↑ 4.96%
Net Income
$-43.2M
↑ 43.11%
Net Profit Margin
-57.69%
↓ 15.38%
Q3 FY23Q/Q Change
Revenue
$17.9M
↑ 1.56%
Net Income
$-9.4M
↑ 91.61%
Net Profit Margin
-52.51%
↓ 24.68%
Q4 FY23Q/Q Change
Revenue
$20.3M
↑ 13.59%
Net Income
$-5.4M
↓ 42.74%
Net Profit Margin
-26.47%
↑ 26.04%
Q1 FY24Q/Q Change
Revenue
$17.4M
↓ 14.26%
Net Income
$-7.9M
↑ 46.42%
Net Profit Margin
-45.2%
↓ 18.73%
Q2 FY24Q/Q Change
Revenue
$16.5M
↓ 5.55%
Net Income
$-9.8M
↑ 24.88%
Net Profit Margin
-59.77%
↓ 14.57%
Q3 FY24Q/Q Change
Revenue
$18.5M
↑ 12.64%
Net Income
$-13.3M
↑ 35.69%
Net Profit Margin
-72.0%
↓ 12.23%
Q4 FY24Q/Q Change
Revenue
$22.5M
↑ 21.39%
Net Income
$-12.2M
↓ 8.87%
Net Profit Margin
-54.05%
↑ 17.95%
FY19Y/Y Change
Profit
$47.3M
↑ 17.2%
FY20Y/Y Change
Profit
$37.7M
↓ 20.26%
FY21Y/Y Change
Profit
$43.7M
↑ 15.84%
FY22Y/Y Change
Profit
$49.7M
↑ 13.89%
FY23Y/Y Change
Profit
$51.7M
↑ 3.99%
FY24Y/Y Change
Profit
$54.2M
↑ 4.75%
Q3 FY23Q/Q Change
Profit
$11.8M
↓ 7.91%
Q4 FY23Q/Q Change
Profit
$15.3M
↑ 29.79%
Q1 FY24Q/Q Change
Profit
$12.5M
↓ 17.95%
Q2 FY24Q/Q Change
Profit
$12.2M
↓ 2.79%
Q3 FY24Q/Q Change
Profit
$14.0M
↑ 14.96%
Q4 FY24Q/Q Change
Profit
$14.9M
↑ 6.37%
FY19Y/Y Change
Operating Cash Flow
$-30.5M
↑ 48.04%
Investing Cash Flow
$-813.0K
↓ 19.58%
Financing Cash Flow
$2.4M
↓ 97.51%
FY20Y/Y Change
Operating Cash Flow
$-28.4M
↓ 6.86%
Investing Cash Flow
$-730.0K
↓ 10.21%
Financing Cash Flow
$2.4M
↓ 2.11%
FY21Y/Y Change
Operating Cash Flow
$-28.0M
↓ 1.43%
Investing Cash Flow
$-9.8M
↑ 1247.81%
Financing Cash Flow
$83.0M
↑ 3403.84%
FY22Y/Y Change
Operating Cash Flow
$-30.7M
↑ 9.85%
Investing Cash Flow
$6.7M
↓ 168.41%
Financing Cash Flow
$207.0K
↓ 99.75%
Q2 FY23Q/Q Change
Operating Cash Flow
$-15.0M
↑ 66.71%
Investing Cash Flow
$-642.0K
↑ 250.82%
Financing Cash Flow
$-62.0K
↓ 112.42%

Neuronetics Technicals Summary

Sell

Neutral

Buy

Neuronetics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Neuronetics (STIM) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Neuronetics Inc logo
57.1%
592.12%
34.83%
90.85%
175.13%
Agilent Technologies Inc. logo
-13.96%
-8.56%
-13.48%
-2.94%
78.81%
Idexx Laboratories, Inc. logo
-5.98%
-6.81%
-21.57%
-15.48%
80.06%
Thermo Fisher Scientific, Inc. logo
-9.71%
-13.63%
-11.38%
-1.97%
77.48%
Danaher Corp. logo
-2.07%
-20.46%
-16.74%
-19.95%
48.71%
Iqvia Holdings Inc. logo
-7.09%
-25.1%
-26.53%
-14.22%
49.88%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Neuronetics Inc logo
NA
NA
NA
-0.56
-1.54
-0.19
NA
0.31
Agilent Technologies Inc. logo
29.02
29.02
2.0
5.57
0.21
0.08
0.01
21.13
Idexx Laboratories, Inc. logo
41.39
41.39
4.36
11.97
0.58
0.23
NA
19.55
Thermo Fisher Scientific, Inc. logo
31.65
31.65
2.02
23.33
0.13
0.05
0.0
130.22
Danaher Corp. logo
38.92
38.92
2.05
7.65
0.08
0.04
0.01
68.9
Iqvia Holdings Inc. logo
24.81
24.81
0.98
11.89
0.23
0.05
NA
34.45
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Neuronetics Inc logo
Buy
$322.1M
175.13%
NA
-50.09%
Agilent Technologies Inc. logo
Buy
$36.1B
78.81%
29.02
19.27%
Idexx Laboratories, Inc. logo
Buy
$35.9B
80.06%
41.39
22.78%
Thermo Fisher Scientific, Inc. logo
Buy
$194.9B
77.48%
31.65
14.77%
Danaher Corp. logo
Buy
$147.2B
48.71%
38.92
16.33%
Iqvia Holdings Inc. logo
Buy
$32.8B
49.88%
24.81
8.91%

About Neuronetics

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
Organization
Neuronetics
Employees
201
CEO
Mr. Keith J. Sullivan
Industry
Health Technology

Management People of Neuronetics

NameTitle
Mr. Keith J. Sullivan
President, CEO & Director
Mr. Stephen J. Furlong M.S.
Executive VP, CFO & Treasurer
Mr. W. Andrew Macan J.D.
Executive VP, GC, Chief Compliance Officer & Corporate Secretary
Mr. Rusty Page
Senior VP of Operations & Quality
Ms. Lisa Metzner-Rosas
Senior VP & Chief Marketing Officer
Ms. Sara Grubbs
Senior VP & Chief Revenue Officer
Mr. Cory S. Anderson
Senior Vice President of R&D and Clinical

Important FAQs about investing in STIM Stock from India :

What is Neuronetics share price today?

Neuronetics share price today stands at $5.42, Open: $5.47 ; Previous Close: $5.06 ; High: $5.84 ; Low: $5.15 ; 52 Week High: $5.92 ; 52 Week Low: $0.52.

The stock opens at $5.47, after a previous close of $5.06. The stock reached a daily high of $5.84 and a low of $5.15, with a 52-week high of $5.92 and a 52-week low of $0.52.

Can Indians buy Neuronetics shares?

Yes, Indians can invest in the Neuronetics (STIM) from India.

With INDmoney, you can buy Neuronetics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Neuronetics at zero transaction cost.

How can I buy Neuronetics shares from India?

It is very easy to buy Neuronetics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Neuronetics (STIM) be purchased?

Yes, you can buy fractional shares of Neuronetics with INDmoney app.

What are the documents required to start investing in Neuronetics stocks?

To start investing in Neuronetics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Neuronetics Stock (STIM)?

Today’s highest price of Neuronetics (STIM) is $5.84.

Today’s lowest price of Neuronetics (STIM) is $5.15.

What is today's market capitalisation of Neuronetics?

Today's market capitalisation of Neuronetics STIM is 322.1M

What is the 52 Week High and Low Range of Neuronetics Stock (STIM)?

  • 52 Week High

    $5.92

  • 52 Week Low

    $0.52

What are the historical returns of Neuronetics (STIM)?

  • 1 Month Returns

    57.1%

  • 3 Months Returns

    592.12%

  • 1 Year Returns

    34.83%

  • 5 Years Returns

    175.13%

Who is the Chief Executive Officer (CEO) of Neuronetics ?

Mr. Keith J. Sullivan is the current Chief Executive Officer (CEO) of Neuronetics.